Search | VHL Search Portal

1.

Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.

van Kleef, Laurens A; Francque, Sven M; Prieto-Ortiz, Jhon E; Sonneveld, Milan J; Sanchez-Luque, Carlos B; Prieto-Ortiz, Robin G; Kwanten, Wilhelmus J; Vonghia, Luisa; Verrijken, An; De Block, Christophe; Gadi, Zouhir; Janssen, Harry L A; de Knegt, Robert J; Brouwer, Willem Pieter.

Gastroenterology ; 2024 Mar 19.

Article in English | MEDLINE | ID: mdl-38513745

2.

Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality.

van Kleef, Laurens A; de Knegt, Robert J; Brouwer, Willem Pieter.

Hepatology ; 77(3): 942-948, 2023 03 01.

Article in English | MEDLINE | ID: mdl-35776631

3.

The Rotterdam Study. Design update and major findings between 2020 and 2024.

Ikram, M Arfan; Kieboom, Brenda C T; Brouwer, Willem Pieter; Brusselle, Guy; Chaker, Layal; Ghanbari, Mohsen; Goedegebure, André; Ikram, M Kamran; Kavousi, Maryam; de Knegt, Rob J; Luik, Annemarie I; van Meurs, Joyce; Pardo, Luba M; Rivadeneira, Fernando; van Rooij, Frank J A; Vernooij, Meike W; Voortman, Trudy; Terzikhan, Natalie.

Eur J Epidemiol ; 39(2): 183-206, 2024 Feb.

Article in English | MEDLINE | ID: mdl-38324224

4.

Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B.

van Campenhout, Margo J H; Rijckborst, Vincent; Brouwer, Willem Pieter; van Oord, Gertine W; Ferenci, Peter; Tabak, Fehmi; Akdogan, Meral; Pinarbasi, Binnur; Simon, Krzysztof; de Knegt, Robert J; Boonstra, André; Janssen, Harry L A; Hansen, Bettina E.

J Viral Hepat ; 26(10): 1156-1163, 2019 10.

Article in English | MEDLINE | ID: mdl-31135084

5.

Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up.

van Campenhout, Margo J H; Brouwer, Willem Pieter; Xie, Qing; Guo, S; Chi, Heng; Qi, Xun; Tabak, Fehmi; Streinu-Cercel, Adrian; Wang, Ji-Yao; Zhang, Ning-Ping; Idilman, Ramazan; Reesink, Hendrik W; Diculescu, Mircea; Simon, Krzysztof; Akdogan, Meral; Mazur, Wlodzimierz; de Knegt, Rob J; Verhey, Elke; Hansen, Bettina E; Janssen, Harry L A.

J Viral Hepat ; 26(1): 109-117, 2019 01.

Article in English | MEDLINE | ID: mdl-30187612

6.

Reply.

van Kleef, Laurens A; de Knegt, Robert J; Brouwer, Willem Pieter.

Hepatology ; 77(3): E45-E46, 2023 Mar 01.

Article in English | MEDLINE | ID: mdl-36057078

7.

Reply.

van Kleef, Laurens A; de Knegt, Robert J; Brouwer, Willem Pieter.

Hepatology ; 77(4): E69-E70, 2023 Apr 01.

Article in English | MEDLINE | ID: mdl-36054493

8.

Treatment of diabetes mellitus in patients with chronic hepatitis B: Are SGLT2 inhibitors hitting the sweet spot?

Sonneveld, Milan J; Brouwer, Willem Pieter; Janssen, Harry L A.

Hepatology ; 78(5): 1334-1336, 2023 11 01.

Article in English | MEDLINE | ID: mdl-37185255

9.

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study.

Brouwer, Willem Pieter; Duran, Servet; Kuijper, Martijn; Ince, Can.

Crit Care ; 23(1): 317, 2019 Sep 18.

Article in English | MEDLINE | ID: mdl-31533846

10.

Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis.

Sharma, Suraj A; Kowgier, Matthew; Hansen, Bettina E; Brouwer, Willem Pieter; Maan, Raoel; Wong, David; Shah, Hemant; Khalili, Korosh; Yim, Colina; Heathcote, E Jenny; Janssen, Harry L A; Sherman, Morris; Hirschfield, Gideon M; Feld, Jordan J.

J Hepatol ; 2017 Aug 24.

Article in English | MEDLINE | ID: mdl-28844936

11.

Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study).

Brouwer, Willem Pieter; Xie, Qing; Sonneveld, Milan J; Zhang, Ningping; Zhang, Qin; Tabak, Fehmi; Streinu-Cercel, Adrian; Wang, Ji-Yao; Idilman, Ramazan; Reesink, Hendrik W; Diculescu, Mircea; Simon, Krzysztof; Voiculescu, Mihai; Akdogan, Meral; Mazur, Wlodzimierz; Reijnders, Jurrien G P; Verhey, Elke; Hansen, Bettina E; Janssen, Harry L A.

Hepatology ; 61(5): 1512-22, 2015 May.

Article in English | MEDLINE | ID: mdl-25348661

12.

Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page?

Sonneveld, Milan J; Brouwer, Willem Pieter; de Man, Robert A.

J Hepatol ; 73(3): 728-729, 2020 09.

Article in English | MEDLINE | ID: mdl-32423630

13.

The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population.

van Kleef, Laurens A; de Knegt, Robert J; Ayada, Ibrahim; Pan, Qiuwei; Brouwer, Willem Pieter.

Hepatol Commun ; 7(4)2023 04 01.

Article in English | MEDLINE | ID: mdl-37026734

14.

Interferon gamma receptor 2 gene variants are associated with liver fibrosis in the general population: the Rotterdam Study.

Plompen, Elisabeth P C; Hansen, Bettina E; Schouten, Jeoffrey N L; Darwish Murad, Sarwa; Loth, Daan W; Brouwer, Willem Pieter; Isaacs, Aaron; Taimr, Pavel; Hofman, Albert; van Duijn, Cornelia M; Uitterlinden, André G; Stricker, Bruno H C; Leebeek, Frank W G; Janssen, Harry L A.

Gut ; 64(4): 692-4, 2015 Apr.

Article in English | MEDLINE | ID: mdl-25301852

15.

Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma.

Ayada, Ibrahim; Li, Jiajing; Brouwer, Willem Pieter; de Knegt, Robert J; Pan, Qiuwei.

Hepatol Int ; 18(3): 1053-1055, 2024 Jun.

Article in English | MEDLINE | ID: mdl-38451406

16.

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B.

Liem, Kin Seng; van Campenhout, Margo J H; Xie, Qing; Brouwer, Willem Pieter; Chi, Heng; Qi, Xun; Chen, Liang; Tabak, Fehmi; Hansen, Bettina E; Janssen, Harry L A.

Aliment Pharmacol Ther ; 49(4): 448-456, 2019 02.

Article in English | MEDLINE | ID: mdl-30689258

17.

Search engine optimization for scientific publications: How one can find your needle in the haystack.

Brouwer, Willem Pieter; Hollenbach, Marcus.

United European Gastroenterol J ; 10(8): 906-908, 2022 10.

Article in English | MEDLINE | ID: mdl-36190015

18.

Real life adherence of chronic hepatitis B patients to entecavir treatment.

van Vlerken, Lotte G; Arends, Pauline; Lieveld, Faydra I; Arends, Joop E; Brouwer, Willem Pieter; Siersema, Peter D; Janssen, Harry L; van Erpecum, Karel J.

Dig Liver Dis ; 47(7): 577-83, 2015 Jul.

Article in English | MEDLINE | ID: mdl-25936691

19.

ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection.

Maan, Raoel; van der Meer, Adriaan J; Brouwer, Willem Pieter; Plompen, Elisabeth P C; Sonneveld, Milan J; Roomer, Robert; van der Eijk, Annemiek A; Groothuismink, Zwier M A; Hansen, Bettina E; Veldt, Bart J; Janssen, Harry L A; Boonstra, Andre; de Knegt, Robert J.

PLoS One ; 10(10): e0139317, 2015.

Article in English | MEDLINE | ID: mdl-26441325

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.

Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality.

The Rotterdam Study. Design update and major findings between 2020 and 2024.

Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B.

Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up.

Reply.

Reply.

Treatment of diabetes mellitus in patients with chronic hepatitis B: Are SGLT2 inhibitors hitting the sweet spot?

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study.

Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis.

Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study).

Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page?

The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population.

Interferon gamma receptor 2 gene variants are associated with liver fibrosis in the general population: the Rotterdam Study.

Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma.

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B.

Search engine optimization for scientific publications: How one can find your needle in the haystack.

Real life adherence of chronic hepatitis B patients to entecavir treatment.

ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection.